TSC2 Ablation Increases Insulin Secretion by Enhancing Mitochondrial Function
Author Information
Author(s): Koyanagi Maki, Asahara Shun-ichiro, Matsuda Tomokazu, Hashimoto Naoko, Shigeyama Yutaka, Shibutani Yuki, Kanno Ayumi, Fuchita Megumi, Mikami Tomoko, Hosooka Tetsutya, Inoue Hiroshi, Matsumoto Michihiro, Koike Masato, Uchiyama Yasuo, Noda Tetsuo, Seino Susumu, Kasuga Masato, Kido Yoshiaki
Primary Institution: Kobe University Graduate School of Medicine
Hypothesis
Does TSC2 ablation affect insulin secretion in pancreatic beta cells?
Conclusion
TSC2 ablation enhances insulin secretion from pancreatic beta cells by increasing mitochondrial biogenesis.
Supporting Evidence
- TSC2 ablation in pancreatic beta cells leads to increased mitochondrial DNA expression.
- Insulin secretion from TSC2 knockdown INS-1 cells was significantly enhanced compared to control cells.
- Rapamycin treatment inhibited mitochondrial DNA expression and ATP production in TSC2 knockdown cells.
- βTSC2−/− mice exhibited hyperinsulinemia due to increased mitochondrial density.
Takeaway
When a specific protein called TSC2 is removed from certain cells in the pancreas, those cells can make more energy and release more insulin, which helps control blood sugar.
Methodology
The study used isolated islets from TSC2 knockout mice and TSC2 knockdown insulinoma cells to measure insulin secretion, ATP content, and mitochondrial gene expression.
Participant Demographics
Mice used were 8 weeks old.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website